Therapeutic drug monitoring using saliva as matrix: an opportunity for linezolid, but challenge for moxifloxacin
Simone H.J. van den Elsen, Onno W. Akkerman, Erwin M. Jongedijk, Mireille Wessels, Samiksha Ghimire, Tjip S. van der Werf, Daan J. Touw, Mathieu S. Bolhuis, Jan‐Willem C. Alffenaar
Abstract
<b>Therapeutic drug monitoring using saliva as matrix is a suitable alternative for serum therapeutic drug monitoring of linezolid, but not for moxifloxacin due to a high variability in saliva-plasma ratios</b>http://bit.ly/2NIYdz7
Topics & Concepts
MoxifloxacinSalivaLinezolidTherapeutic drug monitoringDrugMedicinePharmacologyInternal medicineMicrobiologyAntibioticsBiologyStaphylococcus aureusBacteriaVancomycinGeneticsAntibiotics Pharmacokinetics and EfficacyAntimicrobial Resistance in StaphylococcusPneumonia and Respiratory Infections